°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø º´¸®°ú
Á¤ Âù ±Ç
¼¼°èº¸°Ç±â±¸(World Health Organization, WHO)´Â °©»ó¼±Á¾¾ç¿¡ Á¾¾çºÐ·ù¹ýÀ» 2017³â Á¦4ÆÇÀ» ¹ß°£ÇÑ ÀÌ·¡ 5³â¸¸¿¡ °³Á¤ÇÑ Á¦5ÆÇÀ» ¿Â¶óÀÎÀ¸·Î ¿ì¼± °ø°³Çß´Ù. 2022³â 3¿ù ¹ßÇ¥µÈ ¿Â¶óÀÎ º£Å¸ ¹öÀüÀº °ø½Ä ȨÆäÀÌÁö(https://tumourclassification.iarc.who.int)¸¦ ÅëÇØ À¯·á ¼ºñ½º·Î ¿î¿µµÇ°í ÀÖÀ¸¸ç, Ã¥À¸·Î ÀμâµÇ´Â ÃÖÁ¾º»Àº 2022³â ÇϹݱ⿡ Ãâ½ÃµÉ ¿¹Á¤ÀÌ´Ù. °³Á¤ ÀÛ¾÷ °úÁ¤À» °£´ÜÈ÷ »ìÆ캸¸é, WHO Á¾¾çºÐ·ù Àü¹® À§¿øȸ´Â Á¾¾ç Ä«Å×°í¸®¿Í À¯Çü¿¡ µû¶ó éÅÍ ºÐ·ù ÀÛ¾÷À» ¸¶Ä£ ÈÄ 2021³â 2¿ù±îÁö éÅͺ° °øµ¿ÀúÀÚ ¼·¿Ü¸¦ ¸¶¹«¸®ÇÏ¿´´Ù. ÃÊûÀ» ¹ÞÀº ÀúÀÚµéÀº WHO ¿Â¶óÀÎ Àú¼ú ÇÁ·Î±×·¥À» ÀÌ¿ëÇÏ¿© 2021³â 5¿ù¸»±îÁö 1Â÷ °øµ¿ Àú¼úÀ» ¸¶ÃÆÀ¸¸ç, ÀÌÈÄ ÁýÇàÁøÀÇ °ËÅä¿Í ÀúÀÚ ¼öÁ¤°úÁ¤À» °ÅÃÆ´Ù. ºÏ¹Ì ³»ºÐºñº´¸®ÇÐȸ´Â ÁÖ¿ä ÀúÀÚµéÀ» ÃÊûÇÏ¿© Overview of the 2022 WHO Classification of Thyroid Neoplasms Á¾¼³ ³í¹®À» ÁغñÇÏ¿´À¸¸ç, 2022³â 3¿ù ¿Â¶óÀÎ º£Å¸ ¹öÀü °ø°³ ÀÏÁ¤°ú ¸ÂÃß¾î Endocrine Pathology Àú³Î 3¿ù Ưº°È£¿¡ ¹ßÇ¥ÇÏ¿´´Ù(Âü°í¹®Çå1). Á¾¼³ ³í¹®Àº Á¦5ÆÇ WHO °³Á¤ÆÇÀÇ ÁÖ¿ä °³Á¤ ³»¿ëÀ» Áú¹®À» ÅëÇØ ¸ÕÀú ¹¯°í ±×¸²°ú Ç¥¸¦ È°¿ëÇÏ¿© ´äº¯ÇÏ´Â Çü½ÄÀ¸·Î ¼³¸íÇÏ°í Àֱ⠶§¹®¿¡, Àüü ³»¿ëÀ» ½±°Ô ÆľÇÇÒ ¼ö ÀÖ´Ù.
°©»ó¼±¿¡¼ ³Î¸® »ç¿ëµÇ¾î ¿ÔÀ¸³ª À߸øµÈ ¿ë¾îÀÎ Hürthle cellÀº Á¦5ÆÇ¿¡¼´Â »ç¿ëÇÏÁö ¾Êµµ·Ï ÇÏ¿´À¸¸ç, ¿ë¾î¸¦ oncocytic cell·Î ¹Ù²Ù°í, Hürthle cellÀÌ µé¾î °£ Áø´Ü¸íÀ» ¸ðµÎ oncocyticÀ¸·Î ´ëüÇÏ¿´´Ù. µû¶ó¼, Hürthle cell adenoma/carcinoma ´ë½Å¿¡ oncocytic adenoma/carcinoma·Î Ç¥±âÇÏ¿©¾ß ÇÑ´Ù. Variant ¿ë¾î´Â ¿ì¸®¸»·Î º¯Çü, º¯ÀÌ È¤Àº º¯Á¾À¸·Î ¹ø¿ªµÇ¸ç tall cell variant ¹× columnar cell variant µî°ú °°ÀÌ °©»ó¼±Á¾¾ç¿¡¼´Â ¸Å¿ì Àͼ÷ÇÏ°Ô »ç¿ëµÇ¾î ¿Ô´Ù. ±×·¯³ª variant´Â Á¶Á÷ÇÐÀû º¯Çü(histologic variant) »Ó¸¸ ¾Æ´Ï¶ó À¯ÀüÀÚ º¯ÀÌ(genetic variant)¿¡¼»ç¿ëµÇ°í Àֱ⠶§¹®¿¡, WHO Á¾¾çºÐ·ù´Â ¸ðµç Àå±â¿¡¼ °øÅëÀûÀ¸·Î Á¶Á÷ÇÐÀû º¯Çü¿¡ ´ëÇؼ´Â ¾ÆÇü(subtype)À¸·Î ¿ë¾î¸¦ º¯°æÇÏ¿´´Ù. µû¶ó¼ Á¦5ÆÇ¿¡¼´Â ´õ ÀÌ»ó tall cell variant¿Í °°Àº ¿ë¾î´Â »ç¿ëÇÏÁö ¾ÊÀ¸¸ç, tall cell subtypeÀ¸·Î ºÎ¸£¸ç, tall cell papillary thyroid carcinoma¿Í °°ÀÌ Ç¥±âÇÑ´Ù.
°©»ó¼±¿¡¼ °¡Àå ÈçÇÑ ¼ÒÆ÷(¿©Æ÷)¼¼Æ÷±â¿øÁ¾¾ç(follicular cell-derived neoplasms)Àº Å©°Ô 3°³ÀÇ family (class)ÀÎ ¾ç¼ºÁ¾¾ç, ÀúÀ§ÇèÁ¾¾ç, ¾Ç¼ºÁ¾¾çÀ¸·Î ±¸ºÐµÈ´Ù(Ç¥1). ±âÁ¸ 4ÆÇ¿¡¼ ¾ç¼ºÁ¾¾çÀº adenoma¸¸À» ´Ù·ç°í ÀÖ¾úÀ¸³ª, Á¦5ÆÇ¿¡¼´Â thyroid follicular nodular disease¶ó´Â Áø´Ü¸íÀ» ½Å¼³ÇÏ¿´°í, follicular thyroid adenoma with papillary architecture¶ó´Â Áø´Ü¸íÀ» follicular adenoma¿¡¼ ºÐ¸®ÇÏ¿´´Ù.
Ç¥1. 2022³â¿¡ °³Á¤µÈ Á¦5ÆÇ ¼¼°èº¸°Ç±â±¸ Á¾¾ç ºÐ·ù¹ý¿¡ µû¸¥ °©»ó¼±Á¾¾çÀÇ ºÐ·ù
1. Developmental abnormalities |
Thyroglossal duct cyst |
Other congenital thyroid abnormalities |
2. Follicular cell-derived neoplasms |
Benign tumors |
Thyroid follicular nodular disease |
Follicular thyroid adenoma |
Follicular thyroid adenoma with papillary architecture |
Oncocytic adenoma of the thyroid |
Low risk neoplasms |
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features |
Thyroid tumors of uncertain malignant potential |
Follicular tumor of uncertain malignant potential |
Well-differentiated tumour of uncertain malignant potential |
Hyalinizing trabecular tumor of thyroid |
Malignant neoplasms |
Follicular thyroid carcinoma |
Invasive encapsulated follicular variant papillary carcinoma |
Papillary thyroid carcinoma |
Oncocytic carcinoma of the thyroid |
Follicular-derived carcinomas, high-grade |
Anaplastic follicular cell derived thyroid carcinoma |
3. Thyroid C-cell derived carcinoma |
Medullary thyroid carcinoma |
4. Mixed medullary and follicular-cell derived carcinomas |
Mixed medullary and follicular cell-derived thyroid carcinoma |
Mixed medullary-follicular carcinoma |
Mixed medullary-papillary carcinoma |
5. Salivary gland-type carcinomas of the thyroid |
Mucoepidermoid carcinoma of the thyroid |
Secretory carcinoma of salivary gland type |
6. Thyroid tumors of uncertain histogenesis |
Sclerosing mucoepidermoid carcinoma with eosinophilia |
Cribriform morular thyroid carcinoma |
7. Thymic tumors within the thyroid |
Thymoma family |
Spindle epithelial tumor with thymus-like elements |
Thymic carcinoma family |
Intrathyroidal thymic carcinoma |
8. Embryonal thyroid neoplasms |
Thyroblastoma |